The benefits of anti-VEGF treatment have been firmly established in colorectal cancer and have extended to various other tumor types, such as non-squamous non-small cell lung cancer, glioblastoma multiforme, and ovarian cancer(26–29). The gene discussed is VEGFA; the disease is ovarian carcinoma.